Reported 1 day ago
Doximity Inc. (NYSE:DOCS) saw its stock price surge by 14% after reporting a net income increase of 28% in Q1 2026 and completing a $63 million merger with AI-powered Pathway Medical Inc., known for its high clinical accuracy. The company's revenues also rose by 15%, and it anticipates further growth for the fiscal year.
Source: YAHOO